Eric K. Ashbahian

Array ( [id] => 3583865 [patent_doc_number] => 05580955 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Fragments of neurofibromin (NF1) and method to reverse activated ras induced malignant transformation in mammalian cells' [patent_app_type] => 1 [patent_app_number] => 8/510284 [patent_app_country] => US [patent_app_date] => 1995-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 6614 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580955.pdf [firstpage_image] =>[orig_patent_app_number] => 510284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808593 [patent_doc_number] => 05788965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Modified factor VII' [patent_app_type] => 1 [patent_app_number] => 8/475845 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 18507 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/788/05788965.pdf [firstpage_image] =>[orig_patent_app_number] => 475845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008287 [patent_doc_number] => 05888974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Hybrid human/animal factor VIII' [patent_app_type] => 1 [patent_app_number] => 8/475201 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25245 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888974.pdf [firstpage_image] =>[orig_patent_app_number] => 475201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3861579 [patent_doc_number] => 05795862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Ectoparasite saliva proteins and apparatus to collect such proteins' [patent_app_type] => 1 [patent_app_number] => 8/487001 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 43465 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795862.pdf [firstpage_image] =>[orig_patent_app_number] => 487001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655496 [patent_doc_number] => 05622845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Fermentation method for producing norleucine' [patent_app_type] => 1 [patent_app_number] => 8/470683 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9855 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622845.pdf [firstpage_image] =>[orig_patent_app_number] => 470683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869064 [patent_doc_number] => 05763253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Methods of preparing tissue plasiminogen activator derivative composition' [patent_app_type] => 1 [patent_app_number] => 8/474160 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16504 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763253.pdf [firstpage_image] =>[orig_patent_app_number] => 474160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876172 [patent_doc_number] => 05728566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'Tissue plasminogen activator derivatives' [patent_app_type] => 1 [patent_app_number] => 8/483571 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16554 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728566.pdf [firstpage_image] =>[orig_patent_app_number] => 483571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738307 [patent_doc_number] => 05753486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Human tissue plasminogen activator' [patent_app_type] => 1 [patent_app_number] => 8/472549 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16505 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753486.pdf [firstpage_image] =>[orig_patent_app_number] => 472549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3633005 [patent_doc_number] => 05631149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Variant-type carbohydrate hydrolase, variant gene of the enzyme and method for producing oligosaccharide using the enzyme' [patent_app_type] => 1 [patent_app_number] => 8/470702 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12243 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631149.pdf [firstpage_image] =>[orig_patent_app_number] => 470702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729362 [patent_doc_number] => 05635378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Variant-type carbohydrate hydrolase, variant gene of the enzyme and method for producing oligosaccharide using the enzyme' [patent_app_type] => 1 [patent_app_number] => 8/467831 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12241 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635378.pdf [firstpage_image] =>[orig_patent_app_number] => 467831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045566 [patent_doc_number] => 05869314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Tissue plasminogen activators and derivatives thereof as produced by recombinant means' [patent_app_type] => 1 [patent_app_number] => 8/487456 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16505 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869314.pdf [firstpage_image] =>[orig_patent_app_number] => 487456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824918 [patent_doc_number] => 05783421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'DNA encoding novel polypeptide having Factor Xa inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 8/468347 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21291 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783421.pdf [firstpage_image] =>[orig_patent_app_number] => 468347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727025 [patent_doc_number] => 05652092 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of .beta.-amyloid peptide' [patent_app_type] => 1 [patent_app_number] => 8/462859 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 14653 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652092.pdf [firstpage_image] =>[orig_patent_app_number] => 462859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693721 [patent_doc_number] => 05661008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Recombinant human factor VIII derivatives' [patent_app_type] => 1 [patent_app_number] => 8/462917 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7190 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661008.pdf [firstpage_image] =>[orig_patent_app_number] => 462917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214536 [patent_doc_number] => 06039944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Modified Factor VII' [patent_app_type] => 1 [patent_app_number] => 8/464233 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 19412 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/039/06039944.pdf [firstpage_image] =>[orig_patent_app_number] => 464233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642601 [patent_doc_number] => 05637299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Enhancement of thrombolytic therapy with deglycosylated forms of plasminogen' [patent_app_type] => 1 [patent_app_number] => 8/461172 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6251 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637299.pdf [firstpage_image] =>[orig_patent_app_number] => 461172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729954 [patent_doc_number] => 05665560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Cholesterol oxidase' [patent_app_type] => 1 [patent_app_number] => 8/460114 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7517 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 295 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665560.pdf [firstpage_image] =>[orig_patent_app_number] => 460114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664471 [patent_doc_number] => 05668108 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Preparation of functional human factor VIII and pharmaceutical treatment therewith' [patent_app_type] => 1 [patent_app_number] => 8/447654 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 41 [patent_no_of_words] => 23968 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668108.pdf [firstpage_image] =>[orig_patent_app_number] => 447654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3616922 [patent_doc_number] => 05688503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Modification of plasminogen activators' [patent_app_type] => 1 [patent_app_number] => 8/441358 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 12031 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688503.pdf [firstpage_image] =>[orig_patent_app_number] => 441358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3678657 [patent_doc_number] => 05632986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Phospholipid-targeted thrombolytic agents' [patent_app_type] => 1 [patent_app_number] => 8/441006 [patent_app_country] => US [patent_app_date] => 1995-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9291 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/632/05632986.pdf [firstpage_image] =>[orig_patent_app_number] => 441006 [rel_patent_id] =>[rel_patent_doc_number] =>)